

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.49319156 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.49319156 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.26310397 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.26310397 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.79641411 |
| 6 | glyoxylate metabolic process (GO:0046487) | 6.36564900 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.18491437 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.18491437 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.18491437 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.89916583 |
| 11 | cysteine metabolic process (GO:0006534) | 5.85982489 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.82812220 |
| 13 | * bile acid biosynthetic process (GO:0006699) | 5.63734664 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.60023045 |
| 15 | epoxygenase P450 pathway (GO:0019373) | 5.55162211 |
| 16 | lysine catabolic process (GO:0006554) | 5.45187237 |
| 17 | lysine metabolic process (GO:0006553) | 5.45187237 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 5.38258764 |
| 19 | serine family amino acid catabolic process (GO:0009071) | 5.34407115 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.31382420 |
| 21 | urea cycle (GO:0000050) | 5.25923131 |
| 22 | urea metabolic process (GO:0019627) | 5.25923131 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.03523214 |
| 24 | homocysteine metabolic process (GO:0050667) | 5.01951813 |
| 25 | * fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.00595414 |
| 26 | aromatic amino acid family metabolic process (GO:0009072) | 4.97967428 |
| 27 | protein carboxylation (GO:0018214) | 4.88983396 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.88983396 |
| 29 | amino-acid betaine metabolic process (GO:0006577) | 4.88518670 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 4.86557895 |
| 31 | high-density lipoprotein particle remodeling (GO:0034375) | 4.86491401 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.84303140 |
| 33 | regulation of fibrinolysis (GO:0051917) | 4.83743391 |
| 34 | regulation of protein activation cascade (GO:2000257) | 4.82395487 |
| 35 | drug transmembrane transport (GO:0006855) | 4.79036491 |
| 36 | omega-hydroxylase P450 pathway (GO:0097267) | 4.76682793 |
| 37 | alpha-amino acid catabolic process (GO:1901606) | 4.75058513 |
| 38 | * bile acid metabolic process (GO:0008206) | 4.71435306 |
| 39 | cellular ketone body metabolic process (GO:0046950) | 4.67400022 |
| 40 | urate metabolic process (GO:0046415) | 4.64120406 |
| 41 | tyrosine metabolic process (GO:0006570) | 4.60661881 |
| 42 | regulation of complement activation (GO:0030449) | 4.52823384 |
| 43 | serine family amino acid metabolic process (GO:0009069) | 4.52653708 |
| 44 | drug catabolic process (GO:0042737) | 4.48191642 |
| 45 | phenylpropanoid metabolic process (GO:0009698) | 4.46837196 |
| 46 | cellular amino acid catabolic process (GO:0009063) | 4.46303213 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 4.42992380 |
| 48 | cellular modified amino acid catabolic process (GO:0042219) | 4.41747336 |
| 49 | indolalkylamine metabolic process (GO:0006586) | 4.40219805 |
| 50 | glycine metabolic process (GO:0006544) | 4.37238875 |
| 51 | glutamate metabolic process (GO:0006536) | 4.33810218 |
| 52 | coenzyme catabolic process (GO:0009109) | 4.30366961 |
| 53 | cellular glucuronidation (GO:0052695) | 4.28188749 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.27948913 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.27948913 |
| 56 | reverse cholesterol transport (GO:0043691) | 4.25377926 |
| 57 | serine family amino acid biosynthetic process (GO:0009070) | 4.24879511 |
| 58 | short-chain fatty acid metabolic process (GO:0046459) | 4.24286941 |
| 59 | regulation of cholesterol esterification (GO:0010872) | 4.23928659 |
| 60 | cellular biogenic amine catabolic process (GO:0042402) | 4.23050193 |
| 61 | amine catabolic process (GO:0009310) | 4.23050193 |
| 62 | ethanol metabolic process (GO:0006067) | 4.20995393 |
| 63 | oxidative demethylation (GO:0070989) | 4.18689386 |
| 64 | plasma lipoprotein particle remodeling (GO:0034369) | 4.18676436 |
| 65 | protein-lipid complex remodeling (GO:0034368) | 4.18676436 |
| 66 | macromolecular complex remodeling (GO:0034367) | 4.18676436 |
| 67 | benzene-containing compound metabolic process (GO:0042537) | 4.16639799 |
| 68 | negative regulation of cholesterol transport (GO:0032375) | 4.15053068 |
| 69 | negative regulation of sterol transport (GO:0032372) | 4.15053068 |
| 70 | imidazole-containing compound metabolic process (GO:0052803) | 4.14133315 |
| 71 | exogenous drug catabolic process (GO:0042738) | 4.12041001 |
| 72 | aldehyde catabolic process (GO:0046185) | 4.09665409 |
| 73 | ketone body metabolic process (GO:1902224) | 4.05071772 |
| 74 | ethanol oxidation (GO:0006069) | 4.03912074 |
| 75 | aspartate family amino acid catabolic process (GO:0009068) | 4.02870991 |
| 76 | bile acid and bile salt transport (GO:0015721) | 4.01026514 |
| 77 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.99155608 |
| 78 | acetyl-CoA metabolic process (GO:0006084) | 3.96422256 |
| 79 | * carboxylic acid catabolic process (GO:0046395) | 3.95632473 |
| 80 | * organic acid catabolic process (GO:0016054) | 3.95632473 |
| 81 | phospholipid efflux (GO:0033700) | 3.93762955 |
| 82 | drug transport (GO:0015893) | 3.92836564 |
| 83 | glucuronate metabolic process (GO:0019585) | 3.92539509 |
| 84 | uronic acid metabolic process (GO:0006063) | 3.92539509 |
| 85 | arginine metabolic process (GO:0006525) | 3.89314222 |
| 86 | plasma lipoprotein particle clearance (GO:0034381) | 3.88829254 |
| 87 | biotin metabolic process (GO:0006768) | 3.86202207 |
| 88 | 2-oxoglutarate metabolic process (GO:0006103) | 3.82225767 |
| 89 | * fatty acid beta-oxidation (GO:0006635) | 3.80159606 |
| 90 | * fatty acid oxidation (GO:0019395) | 3.74412605 |
| 91 | carnitine metabolic process (GO:0009437) | 3.72360314 |
| 92 | * monocarboxylic acid catabolic process (GO:0072329) | 3.70439438 |
| 93 | regulation of plasminogen activation (GO:0010755) | 3.67813048 |
| 94 | * lipid oxidation (GO:0034440) | 3.67075166 |
| 95 | regulation of bile acid biosynthetic process (GO:0070857) | 3.67035715 |
| 96 | blood coagulation, intrinsic pathway (GO:0007597) | 3.66830836 |
| 97 | regulation of cholesterol homeostasis (GO:2000188) | 3.62633659 |
| 98 | fibrinolysis (GO:0042730) | 3.62335145 |
| 99 | cholesterol efflux (GO:0033344) | 3.61165219 |
| 100 | * fatty acid catabolic process (GO:0009062) | 3.60403817 |
| 101 | cofactor catabolic process (GO:0051187) | 3.57621448 |
| 102 | flavonoid metabolic process (GO:0009812) | 3.55040549 |
| 103 | drug metabolic process (GO:0017144) | 3.53562360 |
| 104 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.49997428 |
| 105 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.49997428 |
| 106 | cholesterol homeostasis (GO:0042632) | 3.49048555 |
| 107 | valine metabolic process (GO:0006573) | 3.48230651 |
| 108 | NAD biosynthetic process (GO:0009435) | 3.47399944 |
| 109 | branched-chain amino acid catabolic process (GO:0009083) | 3.47107967 |
| 110 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.42691681 |
| 111 | iron ion import (GO:0097286) | 3.28480452 |
| 112 | S-adenosylmethionine metabolic process (GO:0046500) | 3.28307696 |
| 113 | amino acid salvage (GO:0043102) | 3.22627273 |
| 114 | L-methionine salvage (GO:0071267) | 3.22627273 |
| 115 | L-methionine biosynthetic process (GO:0071265) | 3.22627273 |
| 116 | alkaloid metabolic process (GO:0009820) | 3.13937439 |
| 117 | primary alcohol metabolic process (GO:0034308) | 2.99745536 |
| 118 | phosphate ion transmembrane transport (GO:0035435) | 2.95191812 |
| 119 | fructose metabolic process (GO:0006000) | 2.93858109 |
| 120 | xenobiotic metabolic process (GO:0006805) | 2.92122435 |
| 121 | primary alcohol catabolic process (GO:0034310) | 2.91386724 |
| 122 | phosphate ion transport (GO:0006817) | 2.88812072 |
| 123 | branched-chain amino acid metabolic process (GO:0009081) | 2.85575950 |
| 124 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.83559508 |
| 125 | heme transport (GO:0015886) | 2.82159599 |
| 126 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.81350290 |
| 127 | negative regulation of protein activation cascade (GO:2000258) | 2.80923338 |
| 128 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.80792118 |
| 129 | negative regulation of lipase activity (GO:0060192) | 2.80691471 |
| 130 | vitamin biosynthetic process (GO:0009110) | 2.76551645 |
| 131 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.75117158 |
| 132 | protein autoprocessing (GO:0016540) | 2.74907302 |
| 133 | polyketide metabolic process (GO:0030638) | 2.74320276 |
| 134 | doxorubicin metabolic process (GO:0044598) | 2.74320276 |
| 135 | daunorubicin metabolic process (GO:0044597) | 2.74320276 |
| 136 | cellular aldehyde metabolic process (GO:0006081) | 2.73308579 |
| 137 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.72150200 |
| 138 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.69543783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.28279111 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.14897755 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.66661333 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.34725948 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.27241305 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.03679767 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.80303532 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.95943358 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.89966620 |
| 10 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.16780945 |
| 11 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.83215324 |
| 12 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.66784377 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.39401848 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.22749060 |
| 15 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.18261615 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.09534368 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7223924 |
| 18 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.93995975 |
| 19 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.83805320 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.72721620 |
| 21 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.61321936 |
| 22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.54652858 |
| 23 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52700244 |
| 24 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45872944 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.42598209 |
| 26 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.39914125 |
| 27 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.38122009 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38000475 |
| 29 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.36655528 |
| 30 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.27396531 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27299460 |
| 32 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26729496 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.22194009 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22179732 |
| 35 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19855959 |
| 36 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.17300930 |
| 37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13551588 |
| 38 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.11809708 |
| 39 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10419834 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10127083 |
| 41 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.04812746 |
| 42 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04660796 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.03370790 |
| 44 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.01958732 |
| 45 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00695212 |
| 46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00443337 |
| 47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99143194 |
| 48 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.98102074 |
| 49 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93884335 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.93160154 |
| 51 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.90799158 |
| 52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.89087216 |
| 53 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88856905 |
| 54 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.88742902 |
| 55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87447495 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.86998590 |
| 57 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.86814417 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.86420008 |
| 59 | VDR_22108803_ChIP-Seq_LS180_Human | 0.86156966 |
| 60 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.86048183 |
| 61 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.85929792 |
| 62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.85888737 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 0.84341303 |
| 64 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82200258 |
| 65 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81951267 |
| 66 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.79954457 |
| 67 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.79855376 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.79732309 |
| 69 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.78165062 |
| 70 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.77361956 |
| 71 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.77176668 |
| 72 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77032508 |
| 73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74671328 |
| 74 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74610151 |
| 75 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.73913729 |
| 76 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72507871 |
| 77 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.72320117 |
| 78 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.71434458 |
| 79 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71036153 |
| 80 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.70730221 |
| 81 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.70161670 |
| 82 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.69742932 |
| 83 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.69662444 |
| 84 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.68916066 |
| 85 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68783245 |
| 86 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.68418821 |
| 87 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67649059 |
| 88 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66573253 |
| 89 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66027017 |
| 90 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.65854203 |
| 91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.65624061 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.64783797 |
| 93 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.64551287 |
| 94 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64392884 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.64218819 |
| 96 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.63840572 |
| 97 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.62551846 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62347569 |
| 99 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62347569 |
| 100 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61928460 |
| 101 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.60936515 |
| 102 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.60413876 |
| 103 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.60413876 |
| 104 | AR_20517297_ChIP-Seq_VCAP_Human | 0.60386617 |
| 105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.60380709 |
| 106 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.59595895 |
| 107 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.58590136 |
| 108 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.57744149 |
| 109 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.57735665 |
| 110 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.57286298 |
| 111 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.56932333 |
| 112 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.56494682 |
| 113 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.56070194 |
| 114 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54379532 |
| 115 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.53750765 |
| 116 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.53709984 |
| 117 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52066545 |
| 118 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51748371 |
| 119 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.51569452 |
| 120 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51503881 |
| 121 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.50336020 |
| 122 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.49905182 |
| 123 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.49666804 |
| 124 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.49564754 |
| 125 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.49537889 |
| 126 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48156733 |
| 127 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47607231 |
| 128 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.47210019 |
| 129 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.46824442 |
| 130 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45834088 |
| 131 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.45101907 |
| 132 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44083036 |
| 133 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43138070 |
| 134 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.43114151 |
| 135 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42598370 |
| 136 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.40613999 |
| 137 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.40519901 |
| 138 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.40519901 |
| 139 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.40285653 |
| 140 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.39810020 |
| 141 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.39449413 |
| 142 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.39315269 |
| 143 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.39128689 |
| 144 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.39079401 |
| 145 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38835592 |
| 146 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.38370226 |
| 147 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.38139445 |
| 148 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.37990986 |
| 149 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.37892881 |
| 150 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.37606373 |
| 151 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37325932 |
| 152 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.37281240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.18123847 |
| 2 | MP0005360_urolithiasis | 7.96801981 |
| 3 | * MP0005085_abnormal_gallbladder_physiolo | 5.96156622 |
| 4 | MP0005365_abnormal_bile_salt | 5.88234602 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.98720380 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.33080953 |
| 7 | MP0003252_abnormal_bile_duct | 3.92285323 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.27975463 |
| 9 | MP0005332_abnormal_amino_acid | 3.27039799 |
| 10 | MP0003195_calcinosis | 3.10107982 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.93682326 |
| 12 | MP0005083_abnormal_biliary_tract | 2.82882135 |
| 13 | MP0009840_abnormal_foam_cell | 2.79460277 |
| 14 | MP0003123_paternal_imprinting | 2.70590919 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.63958397 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.45162952 |
| 17 | MP0002909_abnormal_adrenal_gland | 2.44929669 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.32193667 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.10546302 |
| 20 | MP0000609_abnormal_liver_physiology | 2.03213530 |
| 21 | * MP0002118_abnormal_lipid_homeostasis | 2.00456212 |
| 22 | * MP0005319_abnormal_enzyme/_coenzyme | 1.86638885 |
| 23 | MP0001764_abnormal_homeostasis | 1.77548432 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.70381064 |
| 25 | MP0003868_abnormal_feces_composition | 1.68823862 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.66637401 |
| 27 | MP0003879_abnormal_hair_cell | 1.56592822 |
| 28 | MP0003186_abnormal_redox_activity | 1.51286935 |
| 29 | MP0005451_abnormal_body_composition | 1.43841263 |
| 30 | MP0004858_abnormal_nervous_system | 1.38887362 |
| 31 | MP0003011_delayed_dark_adaptation | 1.36967298 |
| 32 | MP0001188_hyperpigmentation | 1.33443932 |
| 33 | MP0003283_abnormal_digestive_organ | 1.33300981 |
| 34 | MP0005636_abnormal_mineral_homeostasis | 1.30635199 |
| 35 | MP0009697_abnormal_copulation | 1.30050717 |
| 36 | MP0003315_abnormal_perineum_morphology | 1.28591899 |
| 37 | MP0002234_abnormal_pharynx_morphology | 1.22199261 |
| 38 | MP0002090_abnormal_vision | 1.18244042 |
| 39 | MP0004145_abnormal_muscle_electrophysio | 1.13040956 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.12640986 |
| 41 | MP0005187_abnormal_penis_morphology | 1.11361949 |
| 42 | * MP0000598_abnormal_liver_morphology | 1.10957668 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.10630423 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.09410336 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.08440264 |
| 46 | MP0003122_maternal_imprinting | 1.07260328 |
| 47 | MP0004043_abnormal_pH_regulation | 1.06134379 |
| 48 | MP0005647_abnormal_sex_gland | 1.05641721 |
| 49 | MP0005670_abnormal_white_adipose | 1.04627452 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 1.03784390 |
| 51 | MP0005409_darkened_coat_color | 1.00605627 |
| 52 | MP0009764_decreased_sensitivity_to | 0.99500594 |
| 53 | MP0001756_abnormal_urination | 0.96346357 |
| 54 | MP0004270_analgesia | 0.95868149 |
| 55 | MP0005248_abnormal_Harderian_gland | 0.92762003 |
| 56 | MP0005646_abnormal_pituitary_gland | 0.91591166 |
| 57 | MP0002160_abnormal_reproductive_system | 0.91185768 |
| 58 | MP0002876_abnormal_thyroid_physiology | 0.91135427 |
| 59 | MP0000537_abnormal_urethra_morphology | 0.91097321 |
| 60 | MP0010386_abnormal_urinary_bladder | 0.89300952 |
| 61 | * MP0009642_abnormal_blood_homeostasis | 0.88497633 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 0.86513812 |
| 63 | MP0002938_white_spotting | 0.83947779 |
| 64 | * MP0009763_increased_sensitivity_to | 0.83720585 |
| 65 | MP0005645_abnormal_hypothalamus_physiol | 0.83429674 |
| 66 | * MP0008469_abnormal_protein_level | 0.82178084 |
| 67 | MP0000604_amyloidosis | 0.82119213 |
| 68 | MP0002078_abnormal_glucose_homeostasis | 0.81406496 |
| 69 | MP0005408_hypopigmentation | 0.81173560 |
| 70 | MP0005376_homeostasis/metabolism_phenot | 0.80667452 |
| 71 | MP0002136_abnormal_kidney_physiology | 0.80060584 |
| 72 | MP0010368_abnormal_lymphatic_system | 0.79520745 |
| 73 | MP0005220_abnormal_exocrine_pancreas | 0.79233808 |
| 74 | MP0002557_abnormal_social/conspecific_i | 0.78646487 |
| 75 | MP0005535_abnormal_body_temperature | 0.77998165 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 0.77470244 |
| 77 | MP0009379_abnormal_foot_pigmentation | 0.76975882 |
| 78 | MP0002971_abnormal_brown_adipose | 0.76274093 |
| 79 | MP0006035_abnormal_mitochondrial_morpho | 0.74109457 |
| 80 | MP0002254_reproductive_system_inflammat | 0.73128758 |
| 81 | MP0005266_abnormal_metabolism | 0.71451520 |
| 82 | MP0004130_abnormal_muscle_cell | 0.71378648 |
| 83 | MP0004233_abnormal_muscle_weight | 0.70753926 |
| 84 | MP0001661_extended_life_span | 0.70520106 |
| 85 | MP0001765_abnormal_ion_homeostasis | 0.67594644 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.66984950 |
| 87 | MP0002166_altered_tumor_susceptibility | 0.65830708 |
| 88 | MP0005334_abnormal_fat_pad | 0.65411845 |
| 89 | MP0000003_abnormal_adipose_tissue | 0.65235559 |
| 90 | MP0002928_abnormal_bile_duct | 0.64424591 |
| 91 | MP0002653_abnormal_ependyma_morphology | 0.63374330 |
| 92 | MP0006072_abnormal_retinal_apoptosis | 0.63214694 |
| 93 | MP0005379_endocrine/exocrine_gland_phen | 0.62709392 |
| 94 | MP0008789_abnormal_olfactory_epithelium | 0.62336460 |
| 95 | MP0003121_genomic_imprinting | 0.62263671 |
| 96 | MP0000516_abnormal_urinary_system | 0.59908317 |
| 97 | MP0005367_renal/urinary_system_phenotyp | 0.59908317 |
| 98 | MP0009053_abnormal_anal_canal | 0.57847249 |
| 99 | MP0005666_abnormal_adipose_tissue | 0.57119511 |
| 100 | MP0000372_irregular_coat_pigmentation | 0.55838867 |
| 101 | MP0000013_abnormal_adipose_tissue | 0.55195156 |
| 102 | MP0001324_abnormal_eye_pigmentation | 0.53425011 |
| 103 | MP0005395_other_phenotype | 0.52519185 |
| 104 | MP0005386_behavior/neurological_phenoty | 0.51691070 |
| 105 | MP0004924_abnormal_behavior | 0.51691070 |
| 106 | MP0001905_abnormal_dopamine_level | 0.51479584 |
| 107 | MP0003638_abnormal_response/metabolism_ | 0.51222934 |
| 108 | MP0000230_abnormal_systemic_arterial | 0.50561897 |
| 109 | MP0000462_abnormal_digestive_system | 0.49855064 |
| 110 | MP0005058_abnormal_lysosome_morphology | 0.49606672 |
| 111 | MP0003890_abnormal_embryonic-extraembry | 0.48932886 |
| 112 | MP0000747_muscle_weakness | 0.48697497 |
| 113 | MP0003329_amyloid_beta_deposits | 0.47740900 |
| 114 | MP0003690_abnormal_glial_cell | 0.47377401 |
| 115 | MP0000639_abnormal_adrenal_gland | 0.47220349 |
| 116 | MP0005499_abnormal_olfactory_system | 0.46611674 |
| 117 | MP0005394_taste/olfaction_phenotype | 0.46611674 |
| 118 | MP0005448_abnormal_energy_balance | 0.46410183 |
| 119 | MP0003953_abnormal_hormone_level | 0.45161209 |
| 120 | MP0002168_other_aberrant_phenotype | 0.43537357 |
| 121 | MP0003718_maternal_effect | 0.40094545 |
| 122 | MP0008874_decreased_physiological_sensi | 0.39614914 |
| 123 | MP0009384_cardiac_valve_regurgitation | 0.39605624 |
| 124 | MP0009672_abnormal_birth_weight | 0.37477090 |
| 125 | MP0002796_impaired_skin_barrier | 0.37244125 |
| 126 | MP0003724_increased_susceptibility_to | 0.36362714 |
| 127 | MP0008873_increased_physiological_sensi | 0.35887772 |
| 128 | MP0009115_abnormal_fat_cell | 0.34999158 |
| 129 | MP0002135_abnormal_kidney_morphology | 0.34448518 |
| 130 | MP0003959_abnormal_lean_body | 0.33800406 |
| 131 | MP0004782_abnormal_surfactant_physiolog | 0.33126429 |
| 132 | MP0002269_muscular_atrophy | 0.32327416 |
| 133 | MP0002822_catalepsy | 0.31628223 |
| 134 | MP0005166_decreased_susceptibility_to | 0.31442677 |
| 135 | MP0000538_abnormal_urinary_bladder | 0.31404599 |
| 136 | MP0002970_abnormal_white_adipose | 0.30434790 |
| 137 | MP0008872_abnormal_physiological_respon | 0.30067302 |
| 138 | MP0004147_increased_porphyrin_level | 0.29271662 |
| 139 | MP0005330_cardiomyopathy | 0.28122461 |
| 140 | MP0000579_abnormal_nail_morphology | 0.27832353 |
| 141 | MP0005464_abnormal_platelet_physiology | 0.27403635 |
| 142 | MP0003075_altered_response_to | 0.27260844 |
| 143 | MP0001944_abnormal_pancreas_morphology | 0.24465666 |
| 144 | MP0005595_abnormal_vascular_smooth | 0.24164421 |
| 145 | MP0004264_abnormal_extraembryonic_tissu | 0.22691198 |
| 146 | MP0000249_abnormal_blood_vessel | 0.22607856 |
| 147 | MP0001845_abnormal_inflammatory_respons | 0.21725116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.05892092 |
| 2 | * Intrahepatic cholestasis (HP:0001406) | 6.45568037 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.41017202 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.06152561 |
| 5 | Xanthomatosis (HP:0000991) | 5.86843008 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.62307816 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.56658364 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.80058575 |
| 9 | Hyperglycinuria (HP:0003108) | 4.78266256 |
| 10 | Hyperammonemia (HP:0001987) | 4.78171207 |
| 11 | Ketosis (HP:0001946) | 4.75482638 |
| 12 | Complement deficiency (HP:0004431) | 4.67964237 |
| 13 | Hyperglycinemia (HP:0002154) | 4.67829564 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.66072568 |
| 15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.52955358 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 4.52955358 |
| 17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.28036665 |
| 18 | Hypolipoproteinemia (HP:0010981) | 4.23929080 |
| 19 | Joint hemorrhage (HP:0005261) | 4.23393373 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.20088410 |
| 21 | Hypoglycemic coma (HP:0001325) | 4.05008811 |
| 22 | Epidermoid cyst (HP:0200040) | 3.98733922 |
| 23 | Hyperactive renin-angiotensin system (HP:0000841) | 3.98465598 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.91341196 |
| 25 | Ketoacidosis (HP:0001993) | 3.87326138 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 3.86710173 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.84643213 |
| 28 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.83456086 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 3.76304223 |
| 30 | Gout (HP:0001997) | 3.71473957 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.54857548 |
| 32 | * Fat malabsorption (HP:0002630) | 3.50806839 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.49637512 |
| 34 | Abnormality of nucleobase metabolism (HP:0010932) | 3.45845558 |
| 35 | Delayed CNS myelination (HP:0002188) | 3.41647146 |
| 36 | Abnormality of purine metabolism (HP:0004352) | 3.41339563 |
| 37 | Abnormality of complement system (HP:0005339) | 3.37044098 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 3.34522334 |
| 39 | Conjugated hyperbilirubinemia (HP:0002908) | 3.30900853 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.23356312 |
| 41 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.12455916 |
| 42 | Dicarboxylic aciduria (HP:0003215) | 3.12455916 |
| 43 | Hypercholesterolemia (HP:0003124) | 3.11190724 |
| 44 | Metabolic acidosis (HP:0001942) | 3.10614185 |
| 45 | Generalized aminoaciduria (HP:0002909) | 3.02027465 |
| 46 | Decreased circulating renin level (HP:0003351) | 2.98630083 |
| 47 | Lethargy (HP:0001254) | 2.98093952 |
| 48 | * Hyperbilirubinemia (HP:0002904) | 2.96376649 |
| 49 | Hepatocellular carcinoma (HP:0001402) | 2.95110971 |
| 50 | Proximal tubulopathy (HP:0000114) | 2.87646922 |
| 51 | Vascular calcification (HP:0004934) | 2.84612753 |
| 52 | Steatorrhea (HP:0002570) | 2.83804557 |
| 53 | Cerebral edema (HP:0002181) | 2.75592241 |
| 54 | Abnormality of renin-angiotensin system (HP:0000847) | 2.71327747 |
| 55 | Hyperphosphaturia (HP:0003109) | 2.63258244 |
| 56 | Increased purine levels (HP:0004368) | 2.58322231 |
| 57 | Hyperuricemia (HP:0002149) | 2.58322231 |
| 58 | Malnutrition (HP:0004395) | 2.57396952 |
| 59 | Increased serum pyruvate (HP:0003542) | 2.54475998 |
| 60 | Skin nodule (HP:0200036) | 2.54210407 |
| 61 | Cardiovascular calcification (HP:0011915) | 2.54058899 |
| 62 | Myocardial infarction (HP:0001658) | 2.52791223 |
| 63 | Abnormal urine phosphate concentration (HP:0012599) | 2.51574684 |
| 64 | Abnormal tarsal ossification (HP:0008369) | 2.50199014 |
| 65 | Alkalosis (HP:0001948) | 2.50055115 |
| 66 | Irritability (HP:0000737) | 2.48976047 |
| 67 | Spontaneous abortion (HP:0005268) | 2.47709304 |
| 68 | Abnormality of glycolysis (HP:0004366) | 2.47003535 |
| 69 | Systemic lupus erythematosus (HP:0002725) | 2.46971808 |
| 70 | Vomiting (HP:0002013) | 2.45855599 |
| 71 | Hypoglycemic seizures (HP:0002173) | 2.45108690 |
| 72 | Hypokalemia (HP:0002900) | 2.41603215 |
| 73 | Abnormality of urine glucose concentration (HP:0011016) | 2.41588517 |
| 74 | Glycosuria (HP:0003076) | 2.41588517 |
| 75 | Spastic diplegia (HP:0001264) | 2.41482858 |
| 76 | Late onset (HP:0003584) | 2.40895377 |
| 77 | Osteomalacia (HP:0002749) | 2.39753689 |
| 78 | Enlarged kidneys (HP:0000105) | 2.38512564 |
| 79 | Hydroxyprolinuria (HP:0003080) | 2.33075265 |
| 80 | Abnormality of proline metabolism (HP:0010907) | 2.33075265 |
| 81 | Hyperaldosteronism (HP:0000859) | 2.30442387 |
| 82 | Hypochromic microcytic anemia (HP:0004840) | 2.29861106 |
| 83 | Abnormal gallbladder morphology (HP:0012437) | 2.25398945 |
| 84 | Rickets (HP:0002748) | 2.25394084 |
| 85 | Amelogenesis imperfecta (HP:0000705) | 2.22159605 |
| 86 | Pancreatitis (HP:0001733) | 2.21810428 |
| 87 | Cholelithiasis (HP:0001081) | 2.21639121 |
| 88 | Metabolic alkalosis (HP:0200114) | 2.18138684 |
| 89 | Mitral stenosis (HP:0001718) | 2.17608911 |
| 90 | * Neonatal onset (HP:0003623) | 2.14996563 |
| 91 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.13100716 |
| 92 | Abnormality of chloride homeostasis (HP:0011422) | 2.10367977 |
| 93 | Cholecystitis (HP:0001082) | 2.09554154 |
| 94 | Abnormal gallbladder physiology (HP:0012438) | 2.09554154 |
| 95 | Acute encephalopathy (HP:0006846) | 2.07663191 |
| 96 | Abnormality of magnesium homeostasis (HP:0004921) | 2.06581378 |
| 97 | Reduced antithrombin III activity (HP:0001976) | 2.05791312 |
| 98 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05037241 |
| 99 | Brushfield spots (HP:0001088) | 2.04654865 |
| 100 | Flat acetabular roof (HP:0003180) | 2.04192882 |
| 101 | Opisthotonus (HP:0002179) | 2.00942949 |
| 102 | Abnormality of potassium homeostasis (HP:0011042) | 2.00831860 |
| 103 | Acanthocytosis (HP:0001927) | 1.99769802 |
| 104 | Glomerulonephritis (HP:0000099) | 1.98269568 |
| 105 | Renal cortical cysts (HP:0000803) | 1.96159646 |
| 106 | Nausea (HP:0002018) | 1.95780573 |
| 107 | Abnormal cartilage morphology (HP:0002763) | 1.95451122 |
| 108 | Hypomagnesemia (HP:0002917) | 1.93666351 |
| 109 | Esophageal varix (HP:0002040) | 1.91350698 |
| 110 | Hyperphosphatemia (HP:0002905) | 1.90686764 |
| 111 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.89593898 |
| 112 | Nephrolithiasis (HP:0000787) | 1.88290455 |
| 113 | Hypophosphatemic rickets (HP:0004912) | 1.87833424 |
| 114 | Confusion (HP:0001289) | 1.85574944 |
| 115 | Amyloidosis (HP:0011034) | 1.84849172 |
| 116 | Renal salt wasting (HP:0000127) | 1.84565696 |
| 117 | Renal tubular dysfunction (HP:0000124) | 1.84347569 |
| 118 | Thrombophlebitis (HP:0004418) | 1.84273382 |
| 119 | Abnormality of vitamin metabolism (HP:0100508) | 1.84096502 |
| 120 | Rhabdomyolysis (HP:0003201) | 1.83837819 |
| 121 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.83585403 |
| 122 | Abnormality of carpal bone ossification (HP:0006257) | 1.83455145 |
| 123 | Elevated alkaline phosphatase (HP:0003155) | 1.82975648 |
| 124 | Hypothermia (HP:0002045) | 1.82895904 |
| 125 | Increased circulating renin level (HP:0000848) | 1.82779516 |
| 126 | Chronic bronchitis (HP:0004469) | 1.81385311 |
| 127 | Menorrhagia (HP:0000132) | 1.80272748 |
| 128 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79473008 |
| 129 | Neonatal hypoglycemia (HP:0001998) | 1.79029619 |
| 130 | Hyperglycemia (HP:0003074) | 1.77174946 |
| 131 | Myoglobinuria (HP:0002913) | 1.77080947 |
| 132 | Hypoplasia of the uterus (HP:0000013) | 1.72409756 |
| 133 | Hyperkalemia (HP:0002153) | 1.69822824 |
| 134 | * Sensorimotor neuropathy (HP:0007141) | 1.65937894 |
| 135 | Nephrogenic diabetes insipidus (HP:0009806) | 1.65236411 |
| 136 | Bifid scrotum (HP:0000048) | 1.64190570 |
| 137 | Symptomatic seizures (HP:0011145) | 1.62853121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.87949063 |
| 2 | AKT3 | 4.03846370 |
| 3 | FGFR4 | 4.02912972 |
| 4 | ERN1 | 4.00279048 |
| 5 | STK16 | 3.79876834 |
| 6 | SIK1 | 3.67477719 |
| 7 | PRKD3 | 3.07066137 |
| 8 | INSRR | 2.78407530 |
| 9 | TAOK1 | 2.73797986 |
| 10 | WNK4 | 2.53530440 |
| 11 | ERBB4 | 2.51885227 |
| 12 | STK38L | 2.45054983 |
| 13 | TAOK3 | 2.23888971 |
| 14 | EPHA2 | 2.10908145 |
| 15 | MST1R | 2.10052475 |
| 16 | FER | 2.06359918 |
| 17 | PIK3CG | 2.05748322 |
| 18 | TESK1 | 2.04780091 |
| 19 | PKN2 | 2.03493097 |
| 20 | CAMK1G | 1.94920556 |
| 21 | WNK3 | 1.93050403 |
| 22 | MAPK11 | 1.90617611 |
| 23 | TRIB3 | 1.89767258 |
| 24 | FLT3 | 1.84833932 |
| 25 | MAP2K4 | 1.82962682 |
| 26 | LMTK2 | 1.76060101 |
| 27 | BCR | 1.74304058 |
| 28 | PHKG2 | 1.68844134 |
| 29 | PHKG1 | 1.68844134 |
| 30 | CASK | 1.65326882 |
| 31 | PIK3CA | 1.63635500 |
| 32 | LATS1 | 1.44129393 |
| 33 | BRSK2 | 1.42808575 |
| 34 | PINK1 | 1.42189339 |
| 35 | ERBB3 | 1.41612554 |
| 36 | ARAF | 1.40841732 |
| 37 | OXSR1 | 1.40510289 |
| 38 | NEK9 | 1.39131591 |
| 39 | ABL2 | 1.38345683 |
| 40 | TNK2 | 1.36532816 |
| 41 | PTK6 | 1.29288303 |
| 42 | PDK4 | 1.28845178 |
| 43 | PDK3 | 1.28845178 |
| 44 | DYRK3 | 1.26939862 |
| 45 | MAP3K7 | 1.25891948 |
| 46 | ACVR1B | 1.24249644 |
| 47 | EEF2K | 1.23428251 |
| 48 | MAPKAPK3 | 1.21467957 |
| 49 | TYK2 | 1.20520293 |
| 50 | PRKAA2 | 1.19033366 |
| 51 | MAP3K3 | 1.18566519 |
| 52 | LIMK1 | 1.12696880 |
| 53 | KDR | 1.11952458 |
| 54 | CSNK1A1L | 1.09468809 |
| 55 | FRK | 1.08076944 |
| 56 | MAP2K3 | 1.06660128 |
| 57 | GRK6 | 1.06302264 |
| 58 | CSNK1G3 | 1.06255090 |
| 59 | PRKD2 | 1.06192215 |
| 60 | NEK1 | 1.06171259 |
| 61 | MAP3K12 | 1.05547737 |
| 62 | MAP2K7 | 1.04644276 |
| 63 | CAMKK2 | 1.03054159 |
| 64 | PIM2 | 1.00363844 |
| 65 | NTRK3 | 1.00291391 |
| 66 | MAPK15 | 0.99334834 |
| 67 | JAK2 | 0.98564585 |
| 68 | DAPK2 | 0.92341511 |
| 69 | TIE1 | 0.91581782 |
| 70 | PRKCI | 0.90243121 |
| 71 | CSNK1G2 | 0.89467439 |
| 72 | EPHA4 | 0.88091429 |
| 73 | MAP3K2 | 0.87923294 |
| 74 | MET | 0.86736893 |
| 75 | MAP3K11 | 0.84732770 |
| 76 | MAP4K2 | 0.83559434 |
| 77 | MAP3K4 | 0.82653981 |
| 78 | MAPK4 | 0.82622391 |
| 79 | DYRK1B | 0.80726016 |
| 80 | PRKAA1 | 0.80015942 |
| 81 | PRKCZ | 0.78788857 |
| 82 | TBK1 | 0.78319168 |
| 83 | MAPK12 | 0.77602964 |
| 84 | GSK3A | 0.76314082 |
| 85 | EPHB1 | 0.74968884 |
| 86 | BRSK1 | 0.73498430 |
| 87 | PRKACG | 0.72624049 |
| 88 | SGK494 | 0.72039503 |
| 89 | SGK223 | 0.72039503 |
| 90 | ERBB2 | 0.70392421 |
| 91 | BMPR1B | 0.69932067 |
| 92 | IRAK3 | 0.69245907 |
| 93 | SCYL2 | 0.67900952 |
| 94 | PTK2 | 0.66836696 |
| 95 | MAP3K14 | 0.66706121 |
| 96 | MAP3K10 | 0.66217655 |
| 97 | FGFR2 | 0.64426715 |
| 98 | TAF1 | 0.64128366 |
| 99 | PDK2 | 0.63540140 |
| 100 | CAMK2G | 0.63176891 |
| 101 | JAK1 | 0.62753644 |
| 102 | SGK3 | 0.61736601 |
| 103 | TGFBR2 | 0.58490587 |
| 104 | MINK1 | 0.56911939 |
| 105 | MAPK13 | 0.55975944 |
| 106 | GRK1 | 0.55962269 |
| 107 | MAP2K6 | 0.54909615 |
| 108 | SGK2 | 0.54886737 |
| 109 | EPHB2 | 0.54786398 |
| 110 | PDPK1 | 0.53868138 |
| 111 | SRPK1 | 0.53248873 |
| 112 | OBSCN | 0.50617541 |
| 113 | CDK6 | 0.50344624 |
| 114 | PBK | 0.50296323 |
| 115 | CSNK1A1 | 0.49752600 |
| 116 | PRKCH | 0.48739299 |
| 117 | MST4 | 0.48183488 |
| 118 | TRIM28 | 0.47467818 |
| 119 | VRK2 | 0.45979782 |
| 120 | SGK1 | 0.45916647 |
| 121 | NUAK1 | 0.45796597 |
| 122 | PRKCE | 0.45490034 |
| 123 | MAPK7 | 0.45075228 |
| 124 | MYLK | 0.43926419 |
| 125 | PAK3 | 0.43429118 |
| 126 | AKT2 | 0.42890211 |
| 127 | MAPKAPK5 | 0.42360842 |
| 128 | EIF2AK1 | 0.41916279 |
| 129 | STK39 | 0.41036746 |
| 130 | STK38 | 0.40779562 |
| 131 | LATS2 | 0.40527651 |
| 132 | CSNK1E | 0.40219693 |
| 133 | MAP2K1 | 0.39887295 |
| 134 | DMPK | 0.39710176 |
| 135 | MAP3K6 | 0.38647264 |
| 136 | CSNK1G1 | 0.38126134 |
| 137 | CAMK1D | 0.37156766 |
| 138 | PRKCQ | 0.37153650 |
| 139 | MAP3K5 | 0.36724608 |
| 140 | CAMK2D | 0.36540824 |
| 141 | CDK4 | 0.36459314 |
| 142 | CSK | 0.35445561 |
| 143 | EPHA3 | 0.34412278 |
| 144 | IGF1R | 0.32030222 |
| 145 | TAOK2 | 0.31505853 |
| 146 | IRAK1 | 0.31426498 |
| 147 | MTOR | 0.29838899 |
| 148 | PDK1 | 0.29725700 |
| 149 | PRKCG | 0.29347739 |
| 150 | NME2 | 0.28961453 |
| 151 | CAMK4 | 0.27103559 |
| 152 | IRAK2 | 0.27086446 |
| 153 | ICK | 0.26630048 |
| 154 | PRKCA | 0.26284463 |
| 155 | RET | 0.23406072 |
| 156 | PRKACA | 0.22234501 |
| 157 | LRRK2 | 0.21625082 |
| 158 | CSF1R | 0.21559502 |
| 159 | RIPK1 | 0.21290501 |
| 160 | FGFR3 | 0.20621236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.07554321 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40761439 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.28448454 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.14865875 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.86283274 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.84604049 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73489380 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.68311690 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.64680338 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56013245 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53866945 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.50595365 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.40710067 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.36428443 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27510788 |
| 16 | * Peroxisome_Homo sapiens_hsa04146 | 2.21319422 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99083385 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.97340058 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.91999332 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.83945857 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82365729 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81719712 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.78384123 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.77983929 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.77640879 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.75499646 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68171666 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.66757932 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65839161 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63668559 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.57842136 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56468481 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50587516 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49501300 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.48831775 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43990220 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.42487217 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40986590 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.35609506 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35252243 |
| 41 | Carbon metabolism_Homo sapiens_hsa01200 | 1.33938747 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33932442 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33153380 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30221586 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.29661443 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25491283 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16068783 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.15782584 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13133851 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.06818947 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.05399413 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.05017382 |
| 53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.04059883 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02014506 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97961509 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93306284 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92796384 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.87516308 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85691974 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85614777 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84528913 |
| 62 | Protein export_Homo sapiens_hsa03060 | 0.82719476 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81031559 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71658968 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71482416 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61033791 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.57006687 |
| 68 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.52738730 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38723929 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38560988 |
| 71 | Insulin secretion_Homo sapiens_hsa04911 | 0.37910618 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34402341 |
| 73 | Huntingtons disease_Homo sapiens_hsa05016 | 0.31403452 |
| 74 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29317011 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29088699 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28831199 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.27147142 |
| 78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.26381552 |
| 79 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.25522337 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.25006493 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.23026947 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22085457 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21608796 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.21191649 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20665470 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.18238662 |
| 87 | Cocaine addiction_Homo sapiens_hsa05030 | 0.14250065 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.13156934 |
| 89 | Tight junction_Homo sapiens_hsa04530 | 0.12847072 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.11916831 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10628374 |
| 92 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.10625267 |
| 93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.09909041 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07378366 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03189656 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2098790 |
| 97 | Alzheimers disease_Homo sapiens_hsa05010 | -0.2053431 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1926354 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1913136 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1771833 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1673954 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1524373 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | -0.1443226 |
| 104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1332669 |
| 105 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1192458 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1157093 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1107024 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1081557 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1077283 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1027018 |
| 111 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0993309 |
| 112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0804897 |
| 113 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0683565 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0647603 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0321380 |

